Gene · 116519
APOA5: apolipoprotein A5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. APOA5: apolipoprotein A5. Genes, record 116519. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/116519
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q6Q788 | Apolipoprotein A-V | 366 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents111
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37646 | Q6Q788 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37648 | Q6Q788 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 688 | Q6Q788 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 83 | Q6Q788 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 482 | Q6Q788 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 945 | Q6Q788 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 946 | Q6Q788 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5502 | Q6Q788 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5502 | Q6Q788 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 83 | Q6Q788 | Espacenet |
1 to 10 of 111
See all 111 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,707
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APOA5 papers | Newest fiscal year |
|---|---|---|---|
| P30DK063491 | Diabetes Research Center (DRC) | 21 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 9 | 2025 |
| P30DK020541 | NYR-Diabetes Research Center (NYR-DRC) | 7 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 6 | 2025 |
| R01HL109946 | Using genetics to discover mechanisms of abdominal aortic aneurysm | 6 | 2025 |
| R01NS017950 | Precursors of Stroke Incidence and Prognosis | 6 | 2025 |
| T32HL007208 | Integrated, Multidisciplinary Training in Cardiovascular Research | 6 | 2025 |
| ZIAHG000024 | Genetic analysis of type II diabetes | 6 | 2025 |
| P30DK017047 | Diabetes Research Center | 5 | 2025 |
| P30DK056350 | Nutrition Obesity Research Center (NORC) | 5 | 2025 |
1 to 10 of 1,707Source NIH's project files
See all 1,707 nih grantsPapers2,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erratum. | Kidney Blood Press Res | 2026 | 42814674 | PubTator, text mining | PubMed |
| Multivariate Genome-Wide Association Analysis Identifies Genetic Susceptibility Loci for Metabolic Syndrome in the Korean Genome and Epidemiology Study. | Int J Mol Sci | 2026 | 42794471 | PubTator, text mining | PubMed |
| Dietary Patterns Are Key Predictors of Cardiovascular Risk Beyond Genetic Risk Across Metabolic Syndrome Trajectories in A Korean Prospective Cohort Study. | J Nutr | 2026 | 42772683 | PubTator, text mining | PubMed |
| ADRB3, LEPR, FTO and PPARG variants contribute to obesity-related metabolic syndrome in Brazilian adults: a polygenic risk score approach. | Int J Obes (Lond) | 2026 | 42768086 | PubTator, text mining | PubMed |
| Clinical and functional evidence supporting pathogenicity of a novel APOA5 variant in familial chylomicronemia syndrome. | Arch Endocrinol Metab | 2026 | 42721061 | PubTator, text mining | PubMed |
| Retraction of: APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer. | Aging (Albany NY) | 2026 | 42641125 | PubTator, text mining | PubMed |
| Utility of clinical scoring systems, laboratory, and genetic testing for appropriate classification of patients with severe hypertriglyceridemia in a Latin American cohort. | J Clin Lipidol | 2026 | 42527267 | PubTator, text mining | PubMed |
| Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease. | J Am Coll Cardiol | 2026 | 42524807 | PubTator, text mining | PubMed |
| Genetic determinants of chylomicronemia in Taiwan: Predominance of LPL rare variants and APOA5 p.G185C. | J Clin Lipidol | 2026 | 42509091 | PubTator, text mining | PubMed |
| Multifactorial Chylomicronemia Syndrome With a Rare APOA5 Variant and Recurrent Acute Pancreatitis: A Case Report From Rural Colombia. | Cureus | 2026 | 42460225 | PubTator, text mining | PubMed |
1 to 10 of 2,376
See all 2,376 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/116519
GET https://conductscience.org/api/genes/v1/116519/patents?page=2